Showing 1321-1330 of 4685 results for "".
Removing Obstacles to Dermatologic Care for LGBTQ/GSM Patients
https://practicaldermatology.com/topics/practice-management/removing-obstacles-to-dermatologic-care-for-lgbtqgsm-patients/19935/Members of gender and sexual minority groups may feel less comfortable seeking healthcare than their non-LGBTQ/GSM counterparts. Klint Peebles, MD addresses some of the barriers to access and offers strategies for building more inclusive and welcoming dermatology practices.Psoriasis Update: Understanding the Latest Psoriasis Guidelines
https://practicaldermatology.com/topics/psoriasis/psoriasis-update-understanding-the-latest-psoriasis-guidelines/19777/In a major reversal, the latest psoriasis guidelines recommend against yearly tuberculosis testing for psoriasis patients on biologics who are at low or no risk for TB, says Jashin J. Wu, MD. He also sheds light on studies comparing the 11 biologics that are currently approved for the treatment of pWhat Are You Looking Forward to at SDDS?
https://practicaldermatology.com/topics/practice-management/what-are-you-looking-forward-to-at-sdds/19717/Sarah Lonowski, MD, MBA, Division of Dermatology, University of California Los Angeles, Los Angeles talks about what she hopes to learn at the inaugural SDDS in May. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterContinental San Diego: sddeIntroduction to Nutraceuticals
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/introduction-to-nutraceuticals/18438/What are nutraceuticals and what role may they play in surgical outcomes? Why should aesthetic surgeons care about nutrition? Jason Bloom, MD discusses the rationale behind nutraceuticals to support surgical outcomes and describes his observations after recommending a formulation to his patients.Laser Options for Scars
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-options-for-scars/18814/Advances in laser technology—particularly fractional lasers—offer an effective option for diminishing the appearance of scars, says Jill Waibel, MD. She offers a review of how she's treating all types of scars and skin types, and discusses how and why keloids have been reclassified as a disease.Starting a Practice? Get Educated
https://practicaldermatology.com/topics/practice-management/starting-a-practice-get-educated/19109/You know your medicine, but how well do you know business topics, like human resources, accounting, marketing, staffing, and other aspects of running a practice? Consider hiring a consultant, says Todd Schlesinger, MD, FAAD.DWTV Extra: Culturally Conscious Dermatology
https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-culturally-conscious-dermatology/33939/Candrice Heath, MD, FAAP, FAAD, discusses the issue of appropriately treating patients with tightly coiled hair, and her independent educational initiative on this topic, which included demonstrations at the 2025 American Academy of Dermatology (AAD) Annual Meeting in Orlando, Florida.Hair Loss in Patients With Diverse Skin Tones
https://practicaldermatology.com/programs/practical-dermatology/hair-loss-in-patients-with-skin-of-color/18194/In this first installment of a two-part episode of The Practical Dermatology Podcast, Brooke Jackson, MD, founder and owner of Skin Wellness Dermatology Associates in Durham, NC, and a dermatologic surgeon and dermatologist, speaks about hair loss in patients with diverse skin tones, the timing of hDWTV Extra: Phase 3 Data on Roflumilast for AD, PsO
https://practicaldermatology.com/programs/practical-dermatology/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/Study investigator Melinda Gooderham, MD, talks about the Phase 3 trials of roflumilast cream 0.15% for adults and children down to age 6 with atopic dermatitis and roflumilast foam 0.3% for patients older than 12 with psoriasis of the scalp and body.Connective Tissue Disorders Update 2025: Dr. Vleugels
https://reachmd.com/programs/practical-dermatology/connective-tissue-disorders-update-2025-dr-vleugels/32673/Ruth Ann Vleugels, MD, PhD, recaps her presentation, "Connective Tissue Disorders Update 2025" at Maui Derm 2025. Dr. Vleugels discussed a new therapeutic for systemic lupus, a new FDA-approved option for dermatomyositis, JAK inhibitors, and more.